Breaking News
US Military Ends 72-Year Mandatory Flu Shot Policy
3 Million Ounces of Gold and 28 Million Ounces of Silver Taken Out the Back Door
Palantir and the New Order
Hear from a Missouri farmer: Blake Hurst shares that rising input costs, among other pressures...
Top Tech News
Researcher wins 1 bitcoin bounty for 'largest quantum attack' on underlying tech
Interceptor-Drone Arms-Race Emerges
A startup called Inversion has introduced Arc, a space-based vehicle...
Mining companies are using cosmic rays to find critical minerals
They regrew a severed nerve - by shortening a bone.
New Robot Ants Work Like Real Insects To Build And Dismantle On Their Own
Russian scientists 'are developing the world's first drug to delay ageing' months after
Sam Altman's World ID Expands Biometric Identity Checks
China Tests Directed Energy Beam That Recharges Drones Mid-Flight
Jurassic Park might arrive sooner than expected, just with Dinobots.
New psychedelic-like drug boosts the body's 'feel good' hormone WITHOUT hallucinations -
'AAZ-A-154' is an overlooked molecule that could provide mental health therapy
It stimulates receptors for serotonin, which mediates satisfaction and happiness
In trials on mice it produced rapid and 'long-lasting antidepressant-like effects'
A newly-identified 'psychedelic-like drug' doesn't cause hallucinogenic side effects, scientists reveal.
AAZ-A-154 is a 'previously unstudied' molecule that has the potential to act on beneficial pathways in the brain without causing hallucinations.
It stimulates receptors for serotonin – a key hormone sent between nerve cells in our brain that stabilises our mood, well-being and happiness.
In experiments on mice, AAZ-A-154 produced rapid and long-lasting antidepressant-like effects after a single dose, the US researchers found – and, if synthesised, could be an effective treatment for humans.
Psychedelic drugs have already shown promise for treating neuropsychiatric disorders such as depression and post-traumatic stress disorder (PTSD).
Researchers are now trying to identify alternative medications that offer the benefits of psychedelics without causing often distressing hallucinations.